Download the Adenosine-Pathway Targeted Cancer Immunotherapy Summit Full Event Guide

Harness cutting-edge insights across 3 days of exclusive content from industry heavyweights including AstraZeneca, Harvard Medical School, Phanes Pharmaceuticals, iTeos Pharmaceuticals and more to maximize the commercial opportunity of the adenosine-pathway as a second-generation immuno-oncology target.

Screenshot 2023-05-02 160443

Trouble downloading the brochure? Request a copy here

Here's a Sneak Peak of Topics Being Discussed:

Adenosine’s Role in IO – How Clinical Progress in Adenosine is Shaping the Future of Immunotherapy

Clinical Development Challenges & Rational Strategies For More a Confident Approach to Clinical Trials

Preclinical Modeling In Vivo, In Vitro & Ex Vivo for Confident Clinical Translation of Adenosine Targeted Therapeutics

CD73/CD39 Understanding Biological Principles & Concepts to Enable Fast Development

Exploring Adenosine Receptor Biology & Taking Advantage of its Strengths